Dry Eye Drugs
This is a list of drugs of drugs approved for sale in the indicated countries.
Please contact us with corrections or additions.
FDA-approved drugs for dry eye or related conditions
Cyclosporine ophthalmic solution 0.09%
Indicated to increase tear production in patients with keratoconjunctivitis sicca (dry eye).
Cenegermin, a/k/a recombinant human nerve growth factor
Orphan drug designation for neurotrophic keratitis.
Indicated for treatment of signs and symptoms of dry eye disease.
Cyclosporine ophthalmioc emulsion 0.05%
Indicated to increase tear production in patients whose tear production is presumed to be suppressed due to ocular inflammation associated with KCS.
Cyclosporine 0.1% / Chondroitin Sulfate Emulsion
Compounded by Imprimis
Lipid layer stabilizer
OXERVATE (2018) (cenegermin, a/k/a recombinant human nerve growth factor)
Indicated for moderate or severe neurotrophic keratitis.
Corneal matrix repair therapy
”Intended for management of chronic corneal wound healing, such as PED and persistent corneal dystrophies with associated pain.”
For moderate to severe dry eye
Santen’s cyclosporine drug, approved for severe keratitis in dry eye patients for whom artificial tears aren’t enough.